Patent assignee · SE · COMPANY

Egetis Therapeutics AB

2Patents
2Active
2Granted
46Portfolio score

Filing activity: Jan 10, 2017 → Jan 14, 2022

Most-cited patents

PatentTitleAreaCited byStatus
US12303516B2 Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions Human Necessities 0 Active
US11260060B2 Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.